| Peter E Macgillivray, RPH | |
|
901 Lower Pln, Bradford, VT 05033-8924 | |
| (802) 222-9292 | |
| (802) 222-5549 |
| Full Name | Peter E Macgillivray |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 901 Lower Pln, Bradford, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093172488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033-0002015 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter E Macgillivray, RPH 901 Lower Pln, Bradford, VT 05033-8924 Ph: (802) 222-9292 | Peter E Macgillivray, RPH 901 Lower Pln, Bradford, VT 05033-8924 Ph: (802) 222-9292 |
News Archive
Xenex Healthcare Services LLC, which specializes in developing disinfection technology for healthcare facilities, today announced the commercial launch of its pulsed xenon room disinfection system and the conclusion of the Xenex system's successful trial at a leading U.S. cancer center. The Xenex system, which is now available, is the fastest, safest, and most effective method for the advanced cleaning of hospital rooms in the world today, quickly destroying all major classes of microorganisms (including viruses, bacteria and bacterial spores) without contact or chemicals.
Hospitals and nursing homes have been trying to cut the facility-acquired infection rates, which has worked better for some conditions than others.
The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. The findings appear in a new article in the BMJ on February 25, 2021, showing that natural infection and vaccination together account for around 14% seropositivity rates in England at present.
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £2.5 million by the National Institute for Health Research (NIHR).
› Verified 1 days ago
Melanie Proulx, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 | |
Janeen Wernecke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 | |
Travis Ryan Gross, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 | |
Katherine Frank, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 | |
Adam Luke Kuzmeskus, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 586 Lower Plains Rd, Bradford, VT 05033 Phone: 802-222-3374 | |
Deborah Sleeper, BS PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Lower Pln, Bradford, VT 05033 Phone: 802-222-9292 Fax: 802-222-5549 |